BioCurex Inc. (BOCX) is “One to Watch”
BioCurex, Inc. is a biotechnology company with headquarters in Richmond, British Columbia. The Company is developing products based on patented and proprietary technology in the area of cancer diagnostics. The technology identifies a universal cancer marker known as RECAF. BioCurex has signed licensing agreements for their cancer detection blood tests with Abbott Laboratories (ABT) and Alere (ALR), formerly Inverness Medical Innovations. RECAF is a molecule that is present on cancer cells. However, it is not detected in significant levels on healthy cells or benign tumor cells. It is the receptor for AFP (Alpha-fetoprotein) and has classification as an oncofetal antigen…